Search results
Results from the WOW.Com Content Network
US influenza statistics by flu season. From the Centers for Disease Control and Prevention page called "Disease Burden of Flu": "Each year CDC estimates the burden of influenza in the U.S. CDC uses modeling to estimate the number of flu illnesses, medical visits, hospitalizations, and deaths related to flu that occurred in a given season.
A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations.
The CDC estimates that there have been at least 9.1 million illnesses, with 110,000 hospitalizations for adults. It’s also estimated that 4,700 people have died from flu this season.
Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere . It takes approximately two days to show symptoms.
The CDC indicated that live attenuated influenza vaccine (LAIV), also called the nasal spray vaccine, was not recommended for the 2016–2017 flu season in the United States. [208] Furthermore, the CDC recommends that healthcare personnel who care for severely immunocompromised persons receive injections (TIV or QIV) rather than LAIV. [209]
For premium support please call: 800-290-4726 more ways to reach us
For monitoring influenza A virus in wastewater, CDC compares the most recent weeks of influenza A virus levels recorded at a wastewater site to levels reported between Oct. 1, 2023 and March 2 ...
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.